These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6545280)

  • 1. Use of alkylated proteins in the monitoring of exposure to alkylating agents.
    Farmer PB; Bailey E; Campbell JB
    IARC Sci Publ; 1984; (59):189-98. PubMed ID: 6545280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of cysteine in hemoglobin following exposure to methylating agents.
    Bailey E; Connors TA; Farmer PB; Gorf SM; Rickard J
    Cancer Res; 1981 Jun; 41(6):2514-7. PubMed ID: 7237445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomonitoring of human exposure to alkylating agents by measurement of adducts to haemoglobin or DNA.
    Farmer PB; Bailey E; Green JA; Leung CS; Manson MM
    IARC Sci Publ; 1991; (105):71-7. PubMed ID: 1855925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel uses of mass spectrometry in studies of adducts of alkylating agents with nucleic acids and proteins.
    Farmer PB; Lamb J; Lawley PD
    IARC Sci Publ; 1988; (89):347-55. PubMed ID: 3198219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor.
    Osterman-Golkar S; Ehrenberg L; Segerbäck D; Hällström I
    Mutat Res; 1976 Jan; 34(1):1-10. PubMed ID: 1250243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of hydroxypropylhistidine in haemoglobin as a measure of exposure to propylene oxide using high resolution gas chromatography mass spectrometry.
    Farmer PB; Gorf SM; Bailey E
    Biomed Mass Spectrom; 1982 Feb; 9(2):69-71. PubMed ID: 7059661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of alkylated sites at N-3 and N-7 positions of purines as an indicator for chemical carcinogens.
    Mhaskar DN; Chang MJ; Hart RW; D'Ambrosio SM
    Cancer Res; 1981 Jan; 41(1):223-9. PubMed ID: 7448762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approach to the quantitation of alkylated amino acids in haemoglobin by gas chromatography mass spectrometry.
    Farmer PB; Bailey E; Lamb JH; Connors TA
    Biomed Mass Spectrom; 1980 Jan; 7(1):41-6. PubMed ID: 7397319
    [No Abstract]   [Full Text] [Related]  

  • 9. Mass spectrometric measurement of differential reactivity of cysteine to localize protein-ligand binding sites. Application to tubulin-binding drugs.
    Kim YJ; Pannell LK; Sackett DL
    Anal Biochem; 2004 Sep; 332(2):376-83. PubMed ID: 15325307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemoglobin binding in control of exposure to and risk assessment of aromatic amines.
    Neumann HG
    IARC Sci Publ; 1988; (89):157-65. PubMed ID: 3198198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method for simultaneous identification of human active and active-site alkylated O6-methylguanine-DNA methyltransferase and its possible application for monitoring human exposure to alkylating carcinogens.
    Ayi TC; Oh HK; Lee TK; Li BF
    Cancer Res; 1994 Jul; 54(14):3726-31. PubMed ID: 8033092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines.
    Cloutier JF; Castonguay A; O'Connor TR; Drouin R
    J Mol Biol; 2001 Feb; 306(2):169-88. PubMed ID: 11237592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunoassay for monitoring human exposure to ethylene oxide.
    Wraith MJ; Watson WP; Eadsforth CV; van Sittert NJ; Törnqvist M; Wright AS
    IARC Sci Publ; 1988; (89):271-4. PubMed ID: 3198209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adducts of N-terminal valines in hemoglobin with isoprene diepoxide, a metabolite of isoprene.
    Fred C; Cantillana T; Henderson AP; Golding BT; Törnqvist M
    Rapid Commun Mass Spectrom; 2004; 18(18):2177-84. PubMed ID: 15378724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide.
    Calleman CJ; Ehrenberg L; Jansson B; Osterman-Golkar S; Segerbäck D; Svensson K; Wachtmeister CA
    J Environ Pathol Toxicol; 1978; 2(2):427-42. PubMed ID: 739221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sites in nucleic acids reacting with alkylating agents of differing carcinogenicity of mutagenicity.
    Singer B
    J Toxicol Environ Health; 1977 Jul; 2(6):1279-95. PubMed ID: 328918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro induction of micronuclei by monofunctional methanesulphonic acid esters: possible role of alkylation mechanisms.
    Eder E; Kütt W; Deininger C
    Chem Biol Interact; 2006 Dec; 164(1-2):76-84. PubMed ID: 17011536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkylation of human serum albumin by sulfur mustard in vitro and in vivo: mass spectrometric analysis of a cysteine adduct as a sensitive biomarker of exposure.
    Noort D; Hulst AG; de Jong LP; Benschop HP
    Chem Res Toxicol; 1999 Aug; 12(8):715-21. PubMed ID: 10458705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalent binding of styrene and styrene-7,8-oxide to plasma proteins, hemoglobin and DNA in the mouse.
    Byfält Nordqvist M; Löf A; Osterman-Golkar S; Walles SA
    Chem Biol Interact; 1985 Oct; 55(1-2):63-73. PubMed ID: 4064194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of electrophilic reactivity and especially DNA alkylation in carcinogenesis and mutagenesis.
    Swenson DH
    Dev Toxicol Environ Sci; 1983; 11():247-54. PubMed ID: 6677460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.